Modeling transmission of methicillin-resistant Staphylococcus aureus among patients admitted to a hospital

Infection Control and Hospital Epidemiology

Volumn 26, Issue 7, 2005, Pages 607-615

  Raboud, Janet ^a,b   Saskin, Refik ^b   Simor, Andrew ^d,e   Loeb, Mark ^f   Green, Karen ^c   Low, Don E ^c,d   McGeer, Allison ^c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN;

ARTICLE; BACTERIAL TRANSMISSION; CONTROLLED STUDY; HAND WASHING; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONTE CARLO METHOD; NONHUMAN; SCREENING TEST;

COST-BENEFIT ANALYSIS; CROSS INFECTION; DISEASE TRANSMISSION, HORIZONTAL; HANDWASHING; HOSPITALIZATION; HUMANS; INFECTION CONTROL; MASS SCREENING; METHICILLIN RESISTANCE; MODELS, STATISTICAL; MONTE CARLO METHOD; NURSING STAFF, HOSPITAL; ONTARIO; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WORKLOAD;

EID: 23044515792     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502589     Document Type: Article

References (58)

1. Ruben FL, Norden CW. Staphylococcal infections. In: Evans AS, Brachman PS, eds. Bacterial Infections in Humans: Epidemiology and Control. New York: Plenum; 1991.
2. Voss A, Doebbeling BN. The worldwide prevalence of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 1995;5:101-106.
3. Westh H, Jarlov JO, Kjersem H, Rosdahl VT. The disappearance of multi-resistant Staphylococcus aureus in Denmark: changes in strains of the 83A complex between 1969 and 1989. Clin Infect Dis 1992;14:1186-1194.
4. Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in US hospitals. Infect Control Hosp Epidemiol 1992;13:582-586.
5. National Nosocomial Infections Surveillance System report: data summary from January 1992 to April 2000. Am J Infect Control 2000;28:429-448.
6. Simor A, Ofner-Agostini M, Bryce E, et al. Methicillin-resistant Staphylococcus aureus in Canada: five years of national surveillance. CMAJ 2001;165:21-26.
7. Green K, Saginur M, Fleming CA, Low DE, McGeer A. MRSA in Ontario: can transmission be controlled? Presented at the Community and Hospital Infection Control Association Conference; May 29-31, 2000; Toronto, Ontario, Canada.
8. Cookson BD. Methicillin-resistant Staphylococcus aureus in the community: new battlefronts, or are the battles lost? Infect Control Hosp Epidemiol 2000;21:398-403.
9. Warshawsky B, Hussain Z, Gregson DB, et al. Hospital and community-based surveillance of methicillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor. Infect Control Hosp Epidemiol 2000;21:724-727.
10. Pittet D, Hugonnet S, Harbarth S, et al. The effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356:1307-1312.
11. Goetz A, Posey K, Fleming J, et al. Methicillin-resistant Staphylococcus aureus in the community: a hospital-based study. Infect Control Hosp Epidemiol 1999;20:689-691.
12. Morgan M, Evans-Williams D, Salmon R, Hosein I, Looker DN, Howard A. The population impact of MRSA in a country: the national survey of MRSA in Wales, 1997. J Hosp Infect 2000;44:227-239.
13. Wakefield DS, Helms CM, Massanari RM, Mori M, Pfaller M. Cost of nosocomial infection: relative contributions of laboratory, antibiotic and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control 1988;16:185-192.
14. Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998; 19:32-37.
15. Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995;21:1417-1423.
16. Rubin RJ, Harrington CA, Poon A, Dietrich K, Green JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City. Emerg Infect Dis 1999;5:9-17.
17. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999;20:408-411.
18. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998;158:182-189.
19. Kim T, Oh PI, Simor AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001;22:99-104.
20. Bryce EA, Kerschbaumer V. The cost of doing business: managing MRSA and VRE. Presented at the 4th Decennial International Conference on Nosocomial and Healthcare Associated Infections; March 5-9, 2000; Atlanta, GA.
21. Reboli AC, John JF, Platt CG, Cantey JR. Methicillin-resistant Staphylococcus aureus outbreak at a Veterans' Affairs medical center: importance of carriage of the organism by hospital personnel. Infect Control Hosp Epidemiol 1990;11:291-296.
22. Jorgensen JH. Laboratory and epidemiologic experience with methicillin-resistant Staphylococcus aureus in the USA. Eur J Clin Microbiol 1986;5:693-696.
23. Wenzel RP, ed. Prevention and Control of Nosocomial Infections. Baltimore: Williams and Wilkins; 1993.
24. Crossley K, Loesch D, Landesman B, Mead K, Chern M, Strate R. An outbreak of infections caused by strains of Staphylococcus aurvus resistant to methicillin and aminoglycosides. J Infect Dis 1979;139:273-279.
25. Verhoef J, Beaujean D, Blok H, et al. A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1999;18:416-466.
26. Wenzel RP, Reagan DR, Bertino JS, Baron EJ, Arias K. Methicillin- resistant Staphylococcus aureus outbreak: a consensus panel's definition and management guidelines. Am J Infect Control 1998;26:103-110.
27. Infectious Diseases and Immunization Committee of the Canadian Paediatric Society. Control of methicillin-resistant Staphylococcus aureus in Canadian pediatric institutions is still a worthwhile goal. Paediatrics and Child Health 1999;4:337-341.
28. British Society for Antimicrobial Chemotherapy, Hospital Infection Society, Infection Control Nurses Association. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infections in hospitals. J Hosp Infect 1998;39:253-290.
29. Struelens MJ, Ronveaux O, Jans B, Mertens R, the Groupement pour la Despistage, l'Etude et la Prevention des Infections Hospitalieres. Methicillin-resistant Staphylococcus aureus: epidemiology and control in Belgian hospitals, 1991-1995. Infect Control Hosp Epidemiol 1996;17:503-508.
30. Herwaldt L. Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Am J Med 1999;106(suppl):S11-S18.
31. Haley RW, Cushion NB, Tenover FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995;171:614-621.
32. Giroux E, Pujade G, Legrand P, Cizea F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus in high risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998;27:543-550.
33. Harbarth S, Martin Y, Rohner P, Henry N, Auckenthaler R, Pittet D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000;46:34-39.
34. Rubinovitch B, Pittet D. Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned? J Hosp Infect 2001;47:9-18.
35. Arnold MS, Dempsey JM, Fishman M, McAuley PJ, Tibert C, Vallande NC. The best hospital practices for controlling MRSA: on the cutting edge. Infect Control Hosp Epidemiol 2002;23:65-76.
36. Mylotte JM. Control of methicillin-resistant Staphylococcus aureus: the ambivalence persists. Infect Control Hosp Epidemiol 1994;15:73-77.
37. Styra R, Low DE, Conly J, et al. Quality of life in patients isolated with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26-29, 1999; San Francisco, CA. Abstract 1692.
38. Teare EL, Barrett SP. Is it time to stop searching for MRSA? Stop the ritual of tracing colonized people. Br Med J 1997;314:665-666.
39. Cohen SH, Morita MM, Bradford M. A seven year experience with methicillin-resistant Staphylococcus aureus. Am J Med 1991;91(suppl): S33-S37.
40. Coella R, Jimenez J, Garcia M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 900 patients. Eur J Clin Microbiol Infect Dis 1994;13:74-81.
41. Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost-effective? Infect Control Hosp Epidemiol 1999;20:473-477.
42. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282:1745-1751.
43. Farrington M, Redpath C, Trundle C, Coomber S, Brown NM. Winning the battle but losing the war: methicillin-resistant Staphylococcus aureus infection at a teaching hospital. Quarterly Journal of Medicine 1998;91:539-548.
44. Abudu L, Blair I, Fraise A, Cheng KK. Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol Infect 2001;126:351-356.
45. Eriksen NH, Espersen F, Rosdahl V, Jensen K. Evaluation of methods of detection of nasal carriage of Staphylococcus aureus. Acta Pathologica, Microbiologica et Immunologica Scandinavica 1994;106:407-412.
46. Davies S, Zadik PM. Comparison of methods for the isolation of methicillin-resistant Staphylococcus aureus. J Clin Pathol 1997;50:257-258.
47. Gardam M, Brunton J, Willey B, McGeer A, Low D, Conly D. A blinded comparison of three laboratory protocols for the identification of patients colonized with methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2001;22:152-156.
48. Kitagawa Y, Ueda M, Ando N, et al. Rapid diagnosis of methicillin-resistant Staphylococcus aureus bacteremia by nested polymerase chain reaction. Ann Surg 1996;224:665-671.
49. Raboud JM, Saskin R, Wong K, et al. Patterns of handwashing behavior and visits by healthcare workers to patients on a general medical ward. Infect Control Hosp Epidemiol 2004;25:198-202.
50. Jernigan JA, Clemence MA, Stott GA, et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995;16:686-696.
51. Jernigan JA, Titus MG, Groschel DHM, Getchell-White SI, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996;143:496-504.
52. Centers for Disease Control and Prevention. National Nosocomial Infection Surveillance (NNIS) System report: data summary from January 1990 to May 1999. Am J Infect Control 1999;27:520-532.
53. Karchmer TB, Cage EG, Durbin LJ, Simonton BJ, Farr GM. Cost-effectiveness of active surveillance cultures for controlling methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 2002;51:126-132.
54. Lucet J, Chevret S, Durand-Zaleski I, Chastang-Cregnier B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit. Arch Intern Med 2003;163:181-188.
55. Larson EL, Early E, Cloonan P, Sugruen S, Parides M. An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav Med 2000;26:14-22.
56. Austin DJ, Anderson RM. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. Philos Trans R Soc Lond B Biol Sci 1999;354:721-738.
57. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multi-drug resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362-386.
58. Eveillard M, Martin Y, Hidri N, Boussougant Y, Joly-Guillou ML. Carriage of methicillin-resistant Staphylococcus aureus among hospital employees: prevalence, duration, and transmission to households. Infect Control Hosp Epidemiol 2004;25:114-120.